Literature DB >> 21537924

Identification of high-risk group and therapeutic options in children with liver abscess.

Anshu Srivastava1, Surender Kumar Yachha, Vikas Arora, Ujjal Poddar, Richa Lal, Sanjay S Baijal.   

Abstract

The outcome of children with liver abscess (LA) depends upon prompt diagnosis and intervention. We evaluated the etiology, clinical profile, various interventional modalities of management and outcome of children with LA. A total of 39 hospitalized children (mean age 7.2 ± 3.9 years) with radiologically proven LA were analyzed. Parenteral antibiotics, percutaneous drainage (PD) or open surgical drainage (OSD) was done as required. Cases with ruptured or impending rupture of LA, upper gastrointestinal bleed, jaundice, pleural effusion or consolidation were labeled as "high risk" cases. Triad of fever, pain and hepatomegaly was the most common presentation. Single abscess was present in 66.7% and right lobe was involved in 69.2% of cases. Majority of LA were pyogenic (PLA, 25/39). Amebic liver abscess (ALA) and PLA had similar clinical and laboratory profile except that multiloculated abscess on ultrasonography was a feature of PLA (12/25 vs. 0/11; p = 0.006). Cases with ALA settled significantly more often with antibiotics alone (5/11 vs. 3/25; p = 0.04) than PLA and none required surgery (0/11 vs. 7/25; p = 0.03). Subjects with "high-risk" LA (n - 26) had significantly larger abscesses, more polymorphonuclear leucocytosis (74 ± 15% vs. 61 ± 13%; p = 0.01) in peripheral blood and need of drainage (24/26 vs. 7/13; p = 0.03) than patients with average-risk LA. Based on the results, 38/39 children recovered, with complete abscess resolution in 28, over 48 ± 63.8 days. In conclusion, ALA, although similar in presentation, are uniloculated, and patients with ALA recover more often without drainage than patients with PLA. Patients with "high risk" LA are more common and have a good outcome with drainage. PD, being safe, efficacious and less invasive than OSD, should be the preferred drainage procedure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21537924     DOI: 10.1007/s00431-011-1481-y

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  33 in total

1.  Non-resolving liver abscess with Echinococcus cross-reactivity in a non-endemic region.

Authors:  K Das; P Sakuja; A Aggarwal; A S Puri; M Tatke
Journal:  Indian J Gastroenterol       Date:  2007 Mar-Apr

2.  Hepatic abscess in patients with chronic granulomatous disease.

Authors:  Matthew Lublin; David L Bartlett; David N Danforth; Howard Kauffman; John I Gallin; Harry L Malech; Thomas Shawker; Peter Choyke; David E Kleiner; Douglas J Schwartzentruber; Richard Chang; Ellen S DeCarlo; Steven M Holland
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

3.  Ultrasonographic resolution time for amebic liver abscess.

Authors:  L Ahmed; Z A Salama; A el Rooby; G T Strickland
Journal:  Am J Trop Med Hyg       Date:  1989-10       Impact factor: 2.345

4.  Percutaneous aspiration versus open drainage of liver abscess in children.

Authors:  Shamsul Bari; Khurshid Ahmad Sheikh; Ajaz A Malik; Rauf A Wani; S H Naqash
Journal:  Pediatr Surg Int       Date:  2006-10-26       Impact factor: 1.827

Review 5.  Pyogenic liver abscess: treatment with needle aspiration.

Authors:  S Ch Yu; R Hg Lo; P S Kan; C Metreweli
Journal:  Clin Radiol       Date:  1997-12       Impact factor: 2.350

6.  Intestinal nematodes, Toxocara infection, and pyogenic liver abscess in children: a possible association.

Authors:  S F Moreira-Silva; F E Pereira
Journal:  J Trop Pediatr       Date:  2000-06       Impact factor: 1.165

Review 7.  Liver abscess in children.

Authors:  M P Sharma; Arvind Kumar
Journal:  Indian J Pediatr       Date:  2006-09       Impact factor: 1.967

8.  Percutaneous treatment of liver abscesses: needle aspiration versus catheter drainage.

Authors:  C L Rajak; S Gupta; S Jain; Y Chawla; M Gulati; S Suri
Journal:  AJR Am J Roentgenol       Date:  1998-04       Impact factor: 3.959

9.  Percutaneous drainage of 335 consecutive abscesses: results of primary drainage with 1-year follow-up.

Authors:  R E Lambiase; L Deyoe; J J Cronan; G S Dorfman
Journal:  Radiology       Date:  1992-07       Impact factor: 11.105

10.  Liver abscess in children: a single institutional experience in southern Taiwan.

Authors:  Chia-Chang Tsai; Jiin-Haur Chung; Sheung-Fat Ko; Po-Mai Liu; Chin-Tien Su; Wen-Chieh Li; Chi-Di Liang; Li-Tung Huang; Chung-Bin Huang; Mao-Meng Tiao
Journal:  Acta Paediatr Taiwan       Date:  2003 Sep-Oct
View more
  6 in total

Review 1.  Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000.

Authors:  Elio Castagnola; Eliana Ruberto; Alfredo Guarino
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Amebic liver abscess in children-Experience from Central India.

Authors:  Mayank Jain; Jenisha Jain; Swati Gupta
Journal:  Indian J Gastroenterol       Date:  2016-05

3.  Protocol-based management of 154 cases of pediatric liver abscess.

Authors:  Subhasis Roy Choudhury; Niyaz Ahmed Khan; Rahul Saxena; Partap Singh Yadav; Jigar N Patel; Rajiv Chadha
Journal:  Pediatr Surg Int       Date:  2016-11-08       Impact factor: 1.827

4.  The Value of Ozone in CT-Guided Drainage of Multiloculated Pyogenic Liver Abscesses: A Randomized Controlled Study.

Authors:  Bing Li; Chuan Liu; Lang Wang; Yang Li; Yong Du; Chuan Zhang; Xiao-Xue Xu; Han Feng Yang
Journal:  Can J Gastroenterol Hepatol       Date:  2018-03-08

5.  Computed tomography-guided catheter drainage with ozone in management of pyogenic liver abscess.

Authors:  Xiao-Xue Xu; Chuan Liu; Lang Wang; Yang Li; Han-Feng Yang; Yong Du; Chuan Zhang; Bing Li
Journal:  Pol J Radiol       Date:  2018-06-12

6.  Pediatric Liver Abscess: Trends in the Incidence, Etiology, and Outcomes Based on 20-Years of Experience at a Tertiary Center.

Authors:  Pai-Jui Yeh; Chien-Chang Chen; Ming-Wei Lai; Hung-Yu Yeh; Hsun-Chin Chao
Journal:  Front Pediatr       Date:  2020-03-24       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.